Significance of parenteral iron administration for HCV-positive hemodialysis patients

Japanese Journal of Nephrology

Volumn 44, Issue 4, 2002, Pages 389-395

  Kurihara, Isao ^a   Saito, Takao ^a  

^a Miyagino Hospital   (Japan)

Author keywords

Chronic hepatitis; Hemodialysis; Hepatitis C virus(HCV); Parenteral iron administration; Recombinant human erythropoietin(rHuEPO)

Indexed keywords

AMINOTRANSFERASE; FERRITIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEMATOCRIT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE;

ADULT; AGED; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEPATITIS C ANTIBODIES; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; IRON; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS;

EID: 0036304932     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure
2. European best practice guidelines for the management of anaemia in patients with chronic renal failure
3. Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
4. Measurements of iron status in patients with chronic hepatitis
5. Role of iron in the natural history and clinical course of hepatitis C disease
6. Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy
7. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron
8. Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin
9. Intravenous low-dose iron administration in hemodialysis patients treated with erythropoietin: One-year follow-up study
10. Serum alanine aminotransferase in hepatitis C screening of patients on hemodialysis
11. Interferon treatment for hepatitis C virus infection in patients on haemodialysis
12. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV potitive hepatitis
13. Serum ferritin and hepatic glutathione concentrations in chronic hepatitis C patients related to the hepatitis C virus genotype
14. Relationships between plasma ferritin and aminotransferase profile in haemodialysis patients wit hepatitis C virus
15. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
16. Influence of hepatitis C virus infection upon parenteral iron and erythropoietin responsiveness in regular haemodialysis patients
17. Serum ferritin level required for adequate response to recombinant human erythropoietin in haemodialysis patients with hepatitis C virus infection
18. Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy
19. Neutrophil impairment associated with iron therapy in hemodialysis patients with functional iron deficiency
20. Serum ferritin is a marker of morbidity and mortality in hemodialysis patients